A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Results of a study show convergent genetic adaptation under hypoxia (lack of oxygen) between populations living at ...

Immunotherapy Research: Independently design, plan, and execute experiments involving CAR-T cell engineering, optimization, and evaluation using advanced cellular, molecular, and immunological ...

The firm is hoping that the CRISPR/Cas9-edited TILs will have anti-tumor activity with long-term persistence against various solid tumors.

The DNA of human cells consists of a sequence of about 3.1 billion building blocks. Cells go to great lengths to maintain the ...

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

The Postdoctoral Scholar will lead innovative research projects focused on the development and evaluation of immunotherapies for brain tumors, with an emphasis on CAR-T cell therapy. This position ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center defines a novel approach to understanding how certain proteins called transcription ...